首页> 外文期刊>The Analyst: The Analytical Journal of the Royal Society of Chemistry: A Monthly International Publication Dealing with All Branches of Analytical Chemistry >Identification and quantification of amino acids and related compounds based on Differential Mobility Spectrometry
【24h】

Identification and quantification of amino acids and related compounds based on Differential Mobility Spectrometry

机译:基于差分迁移光谱法的氨基酸和相关化合物的鉴定和定量

获取原文
获取原文并翻译 | 示例
           

摘要

Amino acids and related compounds constitute a class of biomarkers which is analyzed for early diagnosis of metabolic diseases (MDs). Protocols based on liquid chromatography hyphenated to tandem mass spectrometry (LC-MS/MS) are routinely used for MD diagnosis. Our ultimate objective is to evaluate the analytical performance of differential mobility spectrometry (DMS) hyphenated to MS/MS, in the perspective of using DMS-MS/MS as an alternative or complementary method for the topics of emergency in metabolic diagnosis and newborn rapid screening. The aim of the present study is to evaluate the robustness of a DMS-MS/MS protocol for the separation, identification, and quantification of amino acids and related compounds. Performance in terms of peak capacity and separation of isobaric and isomeric species is compared to those using drift tube type ion mobility spectrometry instruments. High reproducibility of the measurement of the DMS compensation voltage (CV) of metabolites shows that this CV parameter, or the corresponding electric field, could be used for application in metabolite identification. Multiple measurements show that the CV value of each AA or related compound is stable over a large period of time (6 months). Potential effects of matrix or concentration of the analytes on the DMS identifier are found to be negligible. Quantification of a selected set of metabolites in human plasmas has been carried out. The method linearity, intra-assay and inter-assay precision, detection limit, quantification limit and trueness analysis were assessed as adequate for both physiological and pathological conditions. Concentration levels of metabolites derived with our DMS-MS protocols were found to be in good agreement with those obtained with routine LC-MS/MS protocols used for the diagnosis of MDs at the Hospital Robert Debré (Paris).
机译:氨基酸和相关化合物构成一类生物标志物,分析了对代谢疾病的早期诊断(MDS)的早期诊断。基于液相色谱的方案连字符为串联质谱(LC-MS / MS)是常规用于MD诊断。我们的终极目的是评估使用DMS-MS / MS作为代谢诊断和新生儿快速筛查的紧急局部主题的替代或互补方法的差异迁移率光谱(DMS)的分析性能。 。本研究的目的是评估DMS-MS / MS方案的鲁棒性,用于分离,鉴定和定量氨基酸和相关化合物。与使用漂移管式离子迁移光谱仪器的峰值容量和异构物种分离的性能进行比较。代谢物的DMS补偿电压(CV)测量的高再现性表明该CV参数或相应的电场可用于代谢物识别中的应用。多次测量表明,每个AA或相关化合物的CV值在大的时间内稳定(6个月)。发现矩阵或分析物浓度对DMS标识符的潜在影响可忽略不计。已经进行了人类等离子体中所选代谢物的定量。该方法线性度,测定和测定间的精度,检测限,定量极限和改革分析被评估为适当的生理和病理条件。发现与我们的DMS-MS方案衍生的代谢物的浓度水平与使用常规LC-MS / MS协议获得的人吻合良好,用于诊断医院罗伯特·德布鲁(巴黎)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号